Maldives vs Panama: Cause of death, by non-communicable diseases, ages 0-4
Maldives
35.3%
in 2021
Panama
35.7%
in 2021
Maldives rank
71st
Panama rank
68th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Maldives
- Panama
How they compare
Panama currently reports 35.7% against 35.3% in Maldives, a difference of 0.4%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Panama ahead.
Maldives ranks 71st and Panama ranks 68th of 185 countries.
Across the 3 decades both report, Maldives averaged higher in 2 and Panama in 1.
Head to head by decade
| Decade | Maldives | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.6% | 32.5% | 15.9% | Panama |
| 2010s | 35.8% | 34.5% | 1.3% | Maldives |
| 2020s | 35.6% | 35.5% | 0.1% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Maldives or Panama?
- Panama, at 35.7% against 35.3% in Maldives as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Maldives and Panama?
- 0.4%, with Panama ahead.
- How many years of comparable data are there for Maldives and Panama?
- 6 years are reported by both, from 2000 to 2021.
- How do Maldives and Panama rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Maldives ranks 71st and Panama ranks 68th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.